The cholesterol-lowering therapy evolocumab reduced the risk of serious adverse cardiac events by nearly one-third in patients with diabetes and…

March 28, 2026 Black adults with high blood pressure who received counseling from a nutritionist and home delivery of groceries…

The investigational drug tonlamarsen, designed to lower blood pressure by reducing the production of angiotensinogen, a protein that turns into…

Researchers at Massachusetts General Brigham have found that evolocumab, an intensive cholesterol-lowering therapy, reduces the risk of a first major…

An analysis of World Happiness Report data and a global survey of gender beliefs found that countries with stronger beliefs…